Increased sensitivity to killing by human serum complement occurs in Salmonella typhimurium strains in which the 95-kilobase virulence plasmid is integrated into the chromosome. This phenotypic change appears to be due to alterations in plasmid gene expression and is reversed by the presence of an autonomous plasmid bearing a cloned region of the virulence plasmid. Accordingly, this region has been termed rsk for reduced serum killing. Sequence analysis of the region reveals that rsk is composed of a series of direct 10-base-pair (bp) repeats with a 21-nucleotide periodicity. Two adjacent repeats are identical, but increasing loss of conservation is apparent with increased distance both 5' and 3' of these highly conserved 10-mers. The smallest isolated sequence which restores the serum-resistant phenotype is only 66 bp long and contains the two identical 10-mers and one degenerate 10-mer (8 of 10 bp conserved) 3' of these. The minimal rsk region of 66 bp does not appear to contain a coding sequence, or a promoter, for a structural gene. It is proposed that the minimal rsk is an isolated regulatory site involved in the regulation of the serum resistance of S. typhimurium. Integration of the 95-kilobase plasmid disrupts the normal regulation of virulence plasmid genes, resulting in an increase in the killing of the bacteria by complement activated by the classical pathway. The introduction of the minimal rsk on a multiple-copy plasmid restores resistance to serum killing, possibly through the titration of a trans-acting regulatory factor.
Integration of the presumed low-copy-number Salmonella typhimurium 95-kilobase (kb) virulence plasmid (33) into the chromosome elevates the susceptibility of smooth strains of S. typhimurium to complement-mediated killing while affecting neither growth in decomplemented serum nor the quantity or the composition of the lipopolysaccharide (36) . This shift from a serum-resistant to a more serum-sensitive state cannot be ascribed to plasmid-mediated insertional mutations in chromosomal genes, since the serum resistance phenotype is restored by the introduction of an autonomous copy of the virulence plasmid into these strains, which continue to maintain the integrated plasmid copy (20, 36) . The chromosomal sites involved in plasmid integration, moreover, differ in both of the strains examined (D. K. Rabert, Ph.D. thesis, University of Michigan, Ann Arbor, 1987) . Furthermore, the serum sensitivity phenotype is not caused by the interruption of a plasmid locus at the site of TnlO insertion or at the site of plasmid integration. Both strains carrying the Tn,O-marked virulence plasmids, pCF610 and pCF810, exhibit wild-type levels of serum resistance and have TnJO inserted at the same site; in this site which is interrupted upon their integration into the chromosome (Rabert, Ph.D. thesis) to create the serum sensitivity phenotype (36) .
Other studies have also correlated the 95-kb plasmid of S. typhimurium with resistance to the bactericidal activity of serum complement (14, 15) and with mouse virulence (3, 12, 13, 20, 30) . Contrary to these findings, Gulig and Curtiss (12) concluded that the 95-kb plasmid did not increase resistance to serum killing. Interpretation of these results is complicated by the use in the latter study of human serum which had been absorbed with salmonellae to specifically eliminate antibody-dependent activation of complement by the classical pathway. VandenBosch et al. (36) , however, demonstrated that differential serum killing of smooth strains of S. typhimurium results primarily from the action of human serum complement activated by the antibody-dependent classical pathway and that smooth strains resist killing by the antibody-independent alternative pathway (36) .
Resistance to complement-mediated killing may be multifactorial. Studies on rough variants of S. typhimurium have demonstrated the quantity and composition of the lipopolysaccharide to be the main determinant of serum resistance of such strains (2, 8) . Hackett et al. (14) have described an 11-kilodalton (kDa) protein, encoded by a gene of the 95-kb plasmid, which confers serum resistance on rough S. typhimurium and Escherichia coli strains (14) . The S. typhimurium 95-kb plasmid-associated serum resistance described by VandenBosch et al. (36) , however, is apparent for S. typhimurium cells of a smooth phenotype but was not detected for rough isolates tested (unpublished data).
The simplest explanation of the serum sensitivity phenotype caused by plasmid integration is that alterations in the levels of expression of plasmid genes follow integration. Accordingly, a study was undertaken to clone and analyze plasmid sequences that reverse this unique serum sensitivity phenotype of smooth strains. This strategy should allow both structural and regulatory genes involved in serum resistance to be recognized. In this study, a cloned fragment of the virulence plasmid that restores serum resistance to a serum-sensitive strain with an integrated plasmid copy is described. The region found to confer serum resistance, termed rsk for reduced serum killing, has the characteristics of a regulatory site.
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MATERIALS AND METHODS
Bacterial strains and plasmids. The serum-sensitive test strain CR6260 (20, 36) carries only a single integrated copy of the virulence plasmid pCF610 (Rabert, Ph.D. thesis). Strain CR6260 was isolated as a tetracycline-sensitive derivative of the wild-type virulent strain CR6600 (20, 36) by introducing a TnJO into the wild-type virulence plasmid pCF601 to give plasmid pCF610 and then selecting for loss of the tetracycline marker (20) . Integration has been shown to involve TnWO sequences and to have occurred by inverse transposition with the concomitant loss of the resistance to tetracycline (Rabert, Ph.D. thesis). Plasmid pCF810 is a TnlOtagged derivative of virulence plasmid pCF801, found originally in strain CR8500 (20, 36) ; it was constructed with the same bacteriophage lysate used to make plasmid pCF610 (20 (27) . Plasmids to be digested with Bcll were prepared from cultures of E. coli GM119, which is deficient in adenine methylase. Exonuclease III deletions were performed by using the Erase-a-base system (Promega Biotec, Madison, Wis.) according to the instructions of the manufacturer.
Initial clones of the virulence plasmid pCF801 were constructed by digesting the 95-kb plasmid with KpnI and ligating the fragments into KpnI-digested pKB111. This vector was derived by the insertion of a pCR1 fragment, which carries a unique KpnI site, between the EcoRI and the HindIII sites of pBR322 (5) .
Transformations were performed essentially as described by Davis et al. (7) for the transfection of bacteriophage lambda DNA. Plasmid constructs were transformed initially into either E. coli HB101 or S. typhimurium SGSC452 (obtained from K. E. Sanderson, University of Calgary, Calgary, Canada), both of which are rough and deficient in their respective restriction systems. Plasmids from E. coli hosts were modified in S. typhimurium SGSC452 before being transformed into other salmonellae.
TnJO-tagged virulence plasmids were mobilized to S. typhimurium with an F' lac plasmid. Exconjugants were then cured of the F' lac plasmid at 40°C and identified on MacConkey-lactose agar plates containing tetracycline (36) .
All cultures were screened routinely for plasmids by the rapid lysis method of Kado and Liu (21) . Large quantities of plasmid DNA were purified by cesium chloride-density gradient centrifugation (27) Serum resistance assays. Cloned sequences of plasmid pCF801 were transformed into the serum-sensitive strain CR6260, and transformants were examined for serum resistance levels in comparative tests with the progenitor strain CR6600.
Cultures were screened for serum resistance by a modification of the colorimetric assay of Moll et al. (28) . Overnight broth cultures were diluted to 5 x 105 bacteria per ml in Veronal-buffered saline (BR16; Oxoid U.S.A., Inc., Columbia, Md.) containing 1% gelatin and were inoculated into four times the volume of pooled normal human serum (PNHS) in a microdilution plate. Plates were incubated in an atmosphere of 10% CO2 to maintain the correct pH (36) . After 2 h of incubation at 37°C, an equal volume of peptoneglucose broth (1% peptone, 1% glucose, 0.01% bromothymol blue) was added to inactivate the remaining complement and to facilitate bacterial growth, and the plates were reincubated overnight. Cells not damaged by complement are able to grow normally after treatment and effect a color change in the indicator after the fermentation of glucose. In contrast, complement-damaged cells exhibit delayed growth in rich medium and no color change is apparent after the same incubation period.
Serum resistance was measured quantitatively as previously described (36) . Briefly, overnight L broth cultures were diluted in Veronal-buffered saline containing 1% gelatin and inoculated into PNHS at a final concentration of approximately 1 x 105 bacteria per ml and 90% PNHS. Incubation was continued at 37°C in 10% CO2 for 2 h, and viable counts were determined in triplicate. Serum sensitivity was expressed as the percent survival after 2 h of incubation (36) and is defined here as a loss in viability relative to strain CR6600 during this time. Increased serum resistance is defined as significantly higher viable counts by 2 h, compared with strain CR6600.
DNA sequencing. The Sanger dideoxy method was used for DNA sequencing. Sequencing was performed on templates of single-stranded M13 clones grown in E. coli JM101 or double-stranded pBR322 clones grown in E. coli HB101 by using commerical kits (Bethesda Research Laboratories, Inc., Gaithersburg, Md., and Promega Biotec, respectively) and Klenow DNA polymerase. Primers for the pBR322 clones were purchased from New England BioLabs, Inc. Details of the construction of the pBR322 clones are described in Results. M13mpl8 clones were generated from plasmid pCF7096 (Fig. 1 (20) into the KpnI site of plasmid pKB111 (5). The total cloned DNA represents over 60% of plasmid pCF801. Of the six different clones tested for serum resistance in the colorimetric assay, only plasmid pCF7082, which contains a 5.3-kb insert (representing about 5.5% of the total plasmid DNA), conferred resistance to serum killing (Fig. 1) .
Deletion derivatives of plasmid pCF7082 were generated by digestion with either SmaI, BamHI, or EcoRI and by subsequent religation. Only plasmid pCF7096, which contains a 2.1-kb insert bordered by KpnI and BamHI sites, conferred serum resistance to strain CR6260 (Fig. 1 cloned DNA of plasmid pCF801. Plasmids pCF7203, pCF7202, and pCF7204 were produced, respectively, from EcoRI-BclI, BclI-SmaI, and StuI-SmaI double digestions of pCF7123. Plasmid pCF7212 was produced from a Bcll-SmaI digestion of pCF7188. All other plasmids arose from exonuclease III digestion of pCF7123 from the MluI site; X, Y, and Z designate termini generated by exonuclease III digestion from this site. The rsk region is situated between the X and BclI sites. ' Presence (+) or absence (-) of the rsk sequence ( Fig. 1 and 2 ; also see text). NA, Not applicable.
rsk in subsequent sections of this paper. Subsequently, the sequence common to all clones that conferred serum resistance (i.e., the rsk sequence) was subcloned by deleting the Bcll-SmaI fragment of pCR7188 (Fig. 2, plasmid pCF7212) . The control plasmid for this construct was made by deleting the EcoRI-SmaI fragment from plasmid pCF7123 (Fig. 2,  pCF7218) ; serum resistance was not associated with the latter clone. Quantitative measurement of serum resistance. As described previously (36) , strain CR6260 is more serum sensitive than its parental strain, CR6600 (P < 0.001), and acquisition of an autonomous copy of the 95-kb virulence plasmid pCF810 (strain CR7179) ( Table 1 ) not only restores serum resistance (P < 0.001) ( Table 1 ) but also enhances it above that of strain CR6600. The latter feature may be due to increased copy number of some structural gene involved in resistance to the bactericidal activity of PNHS. The net increase in viable counts of strain CR6600 during short-term killing tests varied with the batch of serum and was not always evident. After 6 to 8 h of incubation, however, the viable count of strain CR6600 always increased substantially. In contrast, strain CR6260 exhibited little or no increase in viable counts during this extended incubation time because of continued killing (data not shown).
All derivatives of strain CR6260, harboring plasmids with the rsk sequence described above, also exhibited a statistically higher survival in PNHS after 2 h than did transformants carrying plasmids lacking this sequence (P < 0.001) ( Table 1 ). Small differences in the serum resistance of strains with rsk+ plasmids are apparent. Sequence analysis (see below) has not revealed any defects in their construction, and differences may therefore be due to the influences of DNA sequences contiguous to the rsk region. It is noteworthy that transformants containing the cloned rsk+ sequences are more serum resistant than the progenitor strain CR6600, which carries only an autonomous copy of the wild-type virulence plasmid, but are less resistant than strain CR7179, which carries both an autonomous and an integrated copy of the virulence plasmid.
Sequence determination. The region of the virulence plasmid which restored serum resistance was localized by biological assays to the DNA sequence between the exonuclease III terminus (site X) and the BclI site of plasmid pCF7123 (Fig. 2) . The sequence of plasmid pCF7123 DNA was determined to obtain the sequence of the rsk region and evidence of adjacent structural genes. Sequence determinations were done with the M13 system and by the doublestranded DNA method with the same constructs as were used in the biological assays (see above). The complete sequence of the DNA cloned into plasmid pCF7123, including the rsk region, is given in Fig. 3 . The rsk region between site X and the Bcll site measures 66 bp (nucleotides 521 to 586 in Fig. 3 ). The insert cloned in plasmid pCF7123 is 1,065 bp.
Computer-assisted analysis of the 66-bp rsk region revealed a series of three asymmetric direct 10-mer repeats (Fig. 3) . The two 10-mers positioned 5' within the cloned fragment were identical, whereas the third sequence, 3' to these, had 8 of 10 bases conserved. Further analysis of sequences immediately outside this 66-bp section revealed a fourth 10-mer, 5' of the 66-bp region, in which again 8 of 10 bases were conserved. One of the nonconserved bases in this sequence, however, differed from the nonconserved bases of the degenerate 3' 10-mer sequence. Most significantly, the start of each of these four 10-mer repeats was located precisely 21 bases from the start of the previous 10-mer. Further searches 3' and 5' to the central group of four 10-mers revealed the existence of additional possible 10-mer sequences, the starts of which are spaced at 21-bp intervals. These distal sequences show increasing loss of conservation as the distance from the two highly conserved central 10-mers increases (Fig. 4) . Some of the bases composing the 11-bp spaces between 10-mers also appear to be conserved, particularly at positions 3, 4, and 7 of the spacer sequences (Fig. 4) .
Examination of rsk clones for potential ORF and protein products. Although the functional 66-bp rsk site is too small to encode a protein, rsk could be a regulatory signal influencing the expression of a structural gene on plasmid pCF801 (see below). Since the identification of such a gene would be informative of the role of rsk in wild-type strains, the area surrounding the rsk site was examined for evidence of a structural gene.
Analysis of rsk+ clones for protein products showed that a 40-kDa protein and a 13-kDa protein are produced by plasmid pCF7096 (2.1 kb) and by plasmid pCF7123 (1.1 kb), respectively (Fig. 5) . These proteins were of interest, since either of them could represent gene products initiated from promoters associated with rsk. However, plasmid pCF7188, bearing the 540-bp rsk+ insert, produced no proteins other than those produced by a rsk mutant control plasmid, plasmid pCF7118 (Fig. 5) proteins may be produced by a structural gene controlled by rsk on the native plasmid, pCF801, it is clear that inclusion of these structural genes on the rsk clones is not required in order to generate the Rsk phenotype in strain CR6260.
ReReats: The sequenced insert of plasmid pCF7123 contains eight possible open reading frames (ORF) following ATG start codons that are 40 bp or larger. None of these, however, is associated with classical procaryotic consensus promoter sequences, none extends through the rsk region, and none reads out of rsk from an internal start codon. Moreover, none of the ORF are of sufficient size to accommodate the 13-kDa protein which this plasmid produces. Production of this protein requires sequences 5' of the exonuclease III site X and is probably initiated from a translation start site (ATG) located in pBR322, 53 bp 5' of the vector-insert junction at coordinate 4309. The coding sequence for the 40-kDa protein has not been located but must be associated with sequences distal to the sequenced 1,065-bp region around the rsk site.
Three ORF, with translation start sites at positions 96, 952, and 1031 (Fig. 3) , read out of the insert and terminate in the vector, and therefore they may represent the 5' ends of structural genes which have the rsk site situated upstream of the coding region. The start sites of all three, however, are more than 350 bp 3' from rsk, and, should there be an undetected promoter, it is unlikey that the promoter would coincide with the rsk region to form a classical operator site. DISCUSSION Strain CR6260, unlike strains cured of the 95-kb virulence plasmid, has the entire complement of plasmid DNA (Rabert, Ph.D. thesis) but appears to express the genes associated with serum resistance less fully as a consequence of plasmid integration. The reason for the reduced expression of the putative serum resistance gene(s) is unknown, but the reduced expression does not seem to be due to insertional mutagenesis caused either by the TnJO inserted in the plasmid or by the insertional inactivation of chromosomal serum resistance genes resulting from plasmid integration. Since TnJO-tagged plasmids restore the serum resistance duced by rsk+ and rsk mutant clones ( Fig. 1 and 2 phenotype to strains maintaining an integrated plasmid (36; Rabert, Ph.D. thesis), our cloning strategy had the potential to detect either serum resistance structural genes or transacting regulatory elements of the plasmid which modify the expression of the putative serum resistance gene(s), irrespective of these being chromosomal (12) , or on the (integrated) plasmid (14) . 21-bp periodicity. This and the existence of highly conserved bases within the spacer regions between 10-mer repeats suggest that the rsk regions can be usefully considered a series of 21-mer direct repeats, analogous to the direct repeats seen in the replication regions of the plasmids mini-F (35) and mini-P (1), the binding sites of the bacteriophage transcriptional activators Cl in P22 (4) and cII in lambda (17) , and the binding site of the eucaryotic activator Spl (11) . The organization of these direct repeats allows regions of highly conserved bases to be aligned on the same surface of the DNA helix, which in the case of Spl provides for the cooperative binding of the regulatory factor subunits essential for transcriptional activation (34) . Likewise, alignment of the subunits on the same face of the helix would seem to be required for the clI stabilization of the polymerase complex (17) and for the DNA looping interaction seen at the lambdoid P1 RepA-binding sites (29) .
The failure to identify any significant ORF or consensus promoter sequence within 1,000 bp surrounding the rsk site may indicate that rsk is not directly associated with any structural gene. However, although regulatory sequences are usually located at the promoter, the palindromic binding sites for the deo (6), gal (18, 26) , araBAD (10), glnALG (32) , and lac (23) operons are considerably distant from their promoters, and yet they allow for cooperative interaction with proteins bound to sites adjacent to the promoter (23, 31) . Likewise, RepA dimers bound to the direct repeats of the P1 incA gene can interact with RepA dimers bound to the repA promoter, although the former are separated from the latter by approximately 1,000 bp. Similarly, the direct repeats of the rsk site on pCF801 may also act at a distance from the gene(s) it putatively regulates, thereby explaining the lack of an adjacent ORF. Significantly, repA proteinmediated binding between the incA and repA direct repeats appears to occur in trans when these sites are on separate replicons (29) .
In the cloned state, the 66-bp rsk region does not appear to be translationally active and is far too small to encode the 11-kDa protein reported to confer serum resistance on rough S. typhimurium (14) . This does not exclude the possibility that this 11-kDa protein is required for the serum resistance of the progenitor strain CR6600. Indeed, the ability of the low-copy-number plasmid pCF810 to confer greater serum resistance on strain CR6260 than any of the high-copynumber rsk-bearing plasmids implies that ancillary genes, quite possibly including the serum resistance structural gene(s), are located on the virulence plasmid. Throughout our studies we have not found serum resistance to be restored to rough strains of S. typhimurium or E. coli either by the entire 95-kb plasmid or by clones carrying the rsk region (data not shown). The use of KpnI for the construction of the original clones, however, may have precluded our isolation of this structural gene together with its putative upstream regulatory element (14) . Isolation of both of these components on a high-copy-number plasmid may confer higher levels of serum resistance than does our system. The evidence presented by Gulig and Curtiss (12) conflicts with that of Hackett et al. (14) and suggests that any genes associated with serum resistance are chromosomal. Accordingly, the effects mediated by rsk may occur not only at loci distal on the plasmid but also at chromosomal sites.
On the basis of these observations and the similarity of rsk to known regulatory elements, we propose that rsk represents the binding site of a regulatory molecule and that the rsk regulatory unit is involved in the control of serum resistance genes located on the plasmid or on the chromosome. Integration of the virulence plasmid into the chromosome presumably alters the expression of the gene(s) associated with rsk, perhaps by increasing production of a rsk-binding factor or by increasing the affinity of such a factor for rsk. (Disruption of rsk by plasmid integration, however, cannot explain this phenomenon, since rsk maps to a location at least 1.5 kb from the site of plasmid integration [Rabert, Ph.D. thesis].) These changes could be due to topological alterations in the plasmid DNA consequent upon insertion; precedents for such a mechanism influencing the expression of genes exist (9, 16) . Consistent with the recognized ability of bound regulatory proteins to act at a distance (31) , the structural gene(s) affected by rsk may be at a considerable distance from rsk on plasmid pCF801. The structural gene(s) immediately affected by the formation of the rsk-rsk-binding factor complex may encode either the mediator of serum resistance or another regulatory molecule, either protein or RNA. rsk, therefore, is presumably a cis-acting element on the virulence plasmid and functions in trans in strain CR6260 either as a simple, multiple-copy titration site which sequesters the rsk-binding molecule or acts in a more complex manner involving a protein-mediated DNA-DNA interaction as proposed for incA (29) . In either case, binding of this factor to rsk leads to increased expression of a serum resistance gene. The small differences seen in the serum resistance of strain CR6260 carrying the rsk clones are, if real, probably reflective of the influence of contiguous pBR322 or pCF801 sequences on the formation or stability of this complex.
In conclusion, strain CR6260, which harbors a single integrated copy of the virulence plasmid, behaves very differently in serum killing tests (36) than do cured strains (12; J. L. VandenBosch, D. R. Kurlandsky, R. Urdangaray, and G. W. Jones, submitted for publication). The difference can be ascribed to an alteration in the regulatory mechanism involving the serum-resistance phenotype after plasmid integration. rsk, although only 66 bp long, is able to restore the wild-type serum-resistant state, perhaps by removing effector molecules which normally act to repress serum resistance.
